Clinical trial
Suramin and Paclitaxel in Treating Women With Stage IIIB-IV Breast Cancer
NCT00054028 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00054028 |
|---|---|
| Title | Suramin and Paclitaxel in Treating Women With Stage IIIB-IV Breast Cancer |
| Official title | A Phase I/II Study of Suramin in Combination With Paclitaxel in Advanced (Stage IIIB or IV) Metastatic Breast Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer |
| Intervention type | Drug, Other |
| Interventions | suramin, paclitaxel, pharmacological study |
| Enrollment | 31 |
| Start date | Dec 1, 2002 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Feb 6, 2003 |
| Last update posted | Mar 17, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: